Zydus Cadila gets USFDA nod to market 2 products
Drug firm Zydus Cadila today said it has received final approval from the US health regulator to market Gemfibrozil tablets and Aripiprazole orally d30-08-2018
30-08-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for two products, Gemfibrozil Tablets USP and Aripiprazole Orally Disintegrating Tablets USP30-08-2018
Cadila gets 5 observations from USFDA
Cadila Healthcare has received five observations from USFDA after the inspection of Liva Pharmaceuticals' injectables manufacturing facility. Liva is29-08-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
We wish to inform that the USFDA inspected the injectables manufacturing facility of Liva Pharmaceuticals Ltd. (Liva) which is located at Vadodara, from 20th August 2018 to 28th August 2018. Liva is a 100% subsidiary of Cadila Healthcare Ltd. This was a product specific Pre Approval Inspection. The inspection concluded with 5 observations. Liva will respond to the USFDA within 15 days. It may be noted that at present Liva does not export any products to the US market.29-08-2018
Cadila Healthcare's Biologics facility completes USFDA inspection
Cadila Healthcare has informed the exchanges that the US Food and Drug Administration (FDA) has inspected the drug maker's biologics manufacturing fac24-08-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Cadila Healthcare's Biologics manufacturing facility successfully completes USFDA inspection.24-08-2018
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Cadila Healthcare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here14-08-2018
Growth worries ahead for Cadila Healthcare after Q1 estimate miss
With mega products in US facing rising competition, analysts watchful on new launches14-08-2018
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Announcement of results by the Chairman along with the Scrutinizer''s Consolidated Report.13-08-2018
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of Twenty Third Annual General Meeting of Cadila Healthcare Limited held today i.e. August 13, 2018.13-08-2018